Prognostic factors for long-term outcomes in relapsing-remitting multiple sclerosis [0.03%]
复发缓解型多发性硬化症长期预后的预测因素
Anthony L Traboulsee,Peter Cornelisseª,Magnhild Sandberg-Wollheim et al.
Anthony L Traboulsee et al.
Objective: The objective of this article is to investigate potential clinical and MRI predictors of long-term outcomes in multiple sclerosis (MS). Methods...
Multiple sclerosis in First Nations Canadians: A pilot comparison study [0.03%]
加拿大第一民族人的多发性硬化症：一项初步比较研究
Ruth Ann Marrie,Nicholas Hall,A Dessa Sadovnick
Ruth Ann Marrie
Background: Genetic and clinical characteristics associated with multiple sclerosis (MS) may differ by ethnicity but few studies have evaluated whether characteristics of MS differ between individuals according to First N...
Risk attitudes and risk perceptions in individuals with multiple sclerosis [0.03%]
多发性硬化患者的个人风险态度及感知研究
Bonnie I Glanz,Emily Greeke,Allison LaRussa et al.
Bonnie I Glanz et al.
Background: Little is known about risk attitudes and risk perceptions in multiple sclerosis (MS). Objectives: The objectives of this pa...
Chronic inflammatory demyelinating polyradiculoneuropathy occurring after autologous haematopoietic stem cell transplantation for multiple sclerosis [0.03%]
自身造血干细胞移植治疗多发性硬化后发生的慢性炎症脱髓鞘多神经根神经病
Cecilia Smith Simonsen,Gunnar Hansen,Fredrik Piehl et al.
Cecilia Smith Simonsen et al.
We describe the case of a man in his 40 s with aggressive multiple sclerosis (MS) who received autologous haematopoietic stem cell transplantation (AHSCT) and subsequently developed probable, if not definite, Chronic Inflammatory Demyelinat...
Challenges in the diagnosis and treatment of CNS demyelinating disorders in Zambia [0.03%]
赞比亚中枢神经系统脱髓鞘疾病的诊断和治疗挑战
Dhanashri P Miskin,Altaf Saadi,Laston Chikoya et al.
Dhanashri P Miskin et al.
Demyelinating disease occurs in a population of black adult Zambians whose genetic and environmental risk factors for multiple sclerosis are thought to be rare. The diagnosis of demyelinating disease was based predominantly on compatible cl...
Francois H Jacques,Brian T Harel,Adrian J Schembri et al.
Francois H Jacques et al.
Background: Cognitive dysfunction affects up to 65% of multiple sclerosis (MS) patients and progresses over time. Natalizumab has been shown to be superior to placebo in preserving cognition for the first two years of the...
Relationship between timed 25-foot walk and diffusion tensor imaging in multiple sclerosis [0.03%]
timed 25英尺步行与多发性硬化患者的弥散张量成像之间的关系
Sylvia Klineova,Rebecca Farber,Catarina Saiote et al.
Sylvia Klineova et al.
Objective/background: The majority of multiple sclerosis patients experience impaired walking ability, which impacts quality of life. Timed 25-foot walk is commonly used to gauge gait impairment but results can be broadly...
Distractibility in multiple sclerosis: The role of depression [0.03%]
抑郁症在多发性硬化症 distractibility（注意力分散）中的作用
Viral P Patel,Aaron Zambrana,Lisa As Walker et al.
Viral P Patel et al.
The present study assesses the influence of depression and anxiety on the effects of cognitive distracters in people with multiple sclerosis (MS). Participants completed computerized versions of the Symbol Digit Modalities Test (c-SDMT) wit...
A case of presumed herpes keratouveitis in a patient treated with fingolimod [0.03%]
一名服用芬戈莫德的患者疑似患带状疱疹性角膜结膜炎病例报告
Malissa C Ayers,Devon S Conway
Malissa C Ayers
We discuss a case of presumed bilateral herpes simplex keratouveitis in a 36-year-old multiple sclerosis patient switched to fingolimod from glatiramer acetate. Fingolimod treatment appears to increase the risk of herpesvirus infections, in...
Evaluation of French-language internet sites dealing with multiple sclerosis [0.03%]
评估用法语发布有关多发性硬化的网站信息的质量
Antoine Guéguen,Elisabeth Maillart,Thibault Gallice et al.
Antoine Guéguen et al.
Background: Information available on the internet has changed patient-neurologist relationships. Its evaluation for multiple sclerosis is only partial, regardless of the language used. ...